article · AIDS

SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa

Emmanuelle Papot
Tamara Tovar-Sanchez
Simone Jacoby
Simiso Sokhela
Charles Kouanfack
Kathy Petoumenos
Anchalee Avihingsanon
Margaret Borok
Guillaume Thaurignac
Richard Kaplan
Nnakelu Eriobu
Saye Khoo
Gail Matthews
Alexandra Calmy
Mireille Mpoudi-Etame
Mark N. Polizzotto
María B. Arriaga
Marcelo Losso
Willem DF Venter
Iskandar Azwa
Ahidjo Ayouba
Nagalingeswaran Kumarasamy
Éric Delaporte
Beatriz Grinsztejng
Joana Woods
COHIVE study group∗

2024Open accessUniversity of the Witwatersrand

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This study demonstrates a substantial seroprevalence level of SARS-CoV-2 in PWH in the first quarter of 2021, with a marked disparity with the number of COVID-19 PCR tests reported positive.

Research topics

SARS-CoV-2 and COVID-19 Research
COVID-19 epidemiological studies
COVID-19 Clinical Research Studies

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1097/qad.0000000000004068

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.